search
Back to results

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Primary Purpose

Sleep Disordered Breathing, Obstructive Sleep Apnea

Status
Completed
Phase
Not Applicable
Locations
New Zealand
Study Type
Interventional
Intervention
Trial Nasal mask
Sponsored by
Fisher and Paykel Healthcare
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sleep Disordered Breathing

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult (18+ years of age)
  • Able to give consent
  • Apnea Hypopnea Index (AHI) ≥ 5 on diagnostic night
  • Prescribed a Continuous Positive Airway Pressure (CPAP) device after successful OSA diagnosis
  • Existing nasal or nasal pillow mask user

Exclusion Criteria:

  • Inability to give consent
  • Patients who are in a coma or a decreased level of consciousness.
  • Anatomical or physiological conditions making APAP therapy inappropriate (e.g. unconsolidated facial structure)
  • Commercial drivers who are investigated by New Zealand Transport Agency (NZTA)
  • Current diagnosis of CO2 retention
  • Pregnant or may think they are pregnant.

Sites / Locations

  • Fisher & Paykel Healthcare

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Trial Nasal Mask

Arm Description

Participants to use nasal mask in-home for a week and one night in lab overnight polysomnography.

Outcomes

Primary Outcome Measures

Objective leak data (L/min)
Obtained from the participant's device
Subjective measurement of leak
Subjective Questionnaire
Comfort
Subjective Questionnaire
Stability
Subjective Questionnaire
Draft
Subjective Questionnaire
Noise
Subjective Questionnaire
Objective leak data (L/min)
Obtained from the overnight polysomnography

Secondary Outcome Measures

Preference of the mask
Subjective Questionnaire

Full Information

First Posted
March 13, 2016
Last Updated
July 13, 2017
Sponsor
Fisher and Paykel Healthcare
search

1. Study Identification

Unique Protocol Identification Number
NCT02730273
Brief Title
The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)
Official Title
The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Completed
Study Start Date
March 2016 (undefined)
Primary Completion Date
March 2016 (Actual)
Study Completion Date
April 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fisher and Paykel Healthcare

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This investigation is designed to evaluate the performance (leak and comfort) as well as the participant's overall acceptance of the trial nasal mask amongst Obstructive Sleep Apnea (OSA) participants. An important factor in this investigation will be the testing of two different seal sizes on the participants (medium and large size). A total number of 12 participants who currently use nasal or nasal pillow masks will be recruited for the trial. Participants have been selected based on their anthropometric measurements collected in previous trials (CIA-103). Participants from previous NZ trials may be recruited into this trial with their consent. All the participants will be recruited from the Fisher & Paykel Healthcare Database of subjects with OSA (Ethics Reference NTY/08/06/064), Auckland District Health Board (ADHB) and New Zealand Respiratory and Sleep Institute (NZRSI). Participants will use the trial mask in home for a period of 7 ± 3 days and also 1 overnight polysomnography session at the Fisher & Paykel Healthcare sleep lab. Baseline data will be collected from the participant during the first visit, 7 days of CPAP usage data will be downloaded and stored for analysis. The participant will use the trial device on their usual Continuous or Auto Positive Airway Pressure (CPAP/APAP) setting and device for the duration of the trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Disordered Breathing, Obstructive Sleep Apnea

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
12 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Trial Nasal Mask
Arm Type
Experimental
Arm Description
Participants to use nasal mask in-home for a week and one night in lab overnight polysomnography.
Intervention Type
Device
Intervention Name(s)
Trial Nasal mask
Intervention Description
Nasal mask for the treatment of obstructive sleep apnea (OSA)
Primary Outcome Measure Information:
Title
Objective leak data (L/min)
Description
Obtained from the participant's device
Time Frame
Up to 1 week in-home
Title
Subjective measurement of leak
Description
Subjective Questionnaire
Time Frame
Up to 1 week in-home
Title
Comfort
Description
Subjective Questionnaire
Time Frame
Up to 1 week in-home
Title
Stability
Description
Subjective Questionnaire
Time Frame
Up to 1 week in-home
Title
Draft
Description
Subjective Questionnaire
Time Frame
Up to 1 week in-home
Title
Noise
Description
Subjective Questionnaire
Time Frame
Up to 1 week in-home
Title
Objective leak data (L/min)
Description
Obtained from the overnight polysomnography
Time Frame
1 night
Secondary Outcome Measure Information:
Title
Preference of the mask
Description
Subjective Questionnaire
Time Frame
Up to 1 week in-home

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult (18+ years of age) Able to give consent Apnea Hypopnea Index (AHI) ≥ 5 on diagnostic night Prescribed a Continuous Positive Airway Pressure (CPAP) device after successful OSA diagnosis Existing nasal or nasal pillow mask user Exclusion Criteria: Inability to give consent Patients who are in a coma or a decreased level of consciousness. Anatomical or physiological conditions making APAP therapy inappropriate (e.g. unconsolidated facial structure) Commercial drivers who are investigated by New Zealand Transport Agency (NZTA) Current diagnosis of CO2 retention Pregnant or may think they are pregnant.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kayan Gonda, BSc
Organizational Affiliation
Sponsor Employee
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fisher & Paykel Healthcare
City
Auckland
ZIP/Postal Code
2013
Country
New Zealand

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
For product development purposes only. Data will be deidentified.

Learn more about this trial

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)

We'll reach out to this number within 24 hrs